The impact of restricted provision of publicly funded elective hip and knee joints replacement during the COVID-19 pandemic in England.
Christopher PenfoldAshley W BlomMaria Theresa RedanielTim JonesEmily EylesTim KeenAndrew ElliottAndrew JudgePublished in: PloS one (2023)
The restricted provision of elective hip and knee replacements during the COVID-19 pandemic changed the patient casemix, but did not introduce new inequalities in access to these operations. Patients were younger, had more comorbidities, and stayed in hospital for less time than those treated before the pandemic. Approximately half the number of operations were performed during the pandemic than would have been expected and the effect was greatest for revision knee replacements.
Keyphrases
- sars cov
- total knee arthroplasty
- coronavirus disease
- end stage renal disease
- newly diagnosed
- patients undergoing
- ejection fraction
- palliative care
- chronic kidney disease
- healthcare
- case report
- knee osteoarthritis
- peritoneal dialysis
- patient reported outcomes
- total hip arthroplasty
- acute care
- adverse drug
- patient reported